Collectively, these results demonstrate that i.c.v delivery of VEGF-C before stroke significantly improves early locomotor activity, locomotor gait disturbances, as well as general and focal neurological outcome post-stroke, whereas it has no effect on tested sensorimotor functions. Here, VEGFC is linked to stroke disorder.